Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes

Study Identifier:
P06-001
ClinicalTrials.gov Identifier:
NCT01192425
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete

Study Details

Medical Condition
  • Unmapped
Study Drug
    Date
    N/A - N/A
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    N/A
    Patient Requirements
    Sex: Female & Male
    Age: 10+ years
    Requirements Information
    Sex
    Female & Male
    Age
    10+ years

    Study Details

    Medical Condition
    • Unmapped
    Study Drug
      Date
      N/A - N/A
      Phase 1
      Phase 2
      Phase 3
      Phase 4
      N/A
      Patient Requirements
      Sex: Female & Male
      Age: 10+ years years
      Requirements Information

      Protocol Summary

      Examine red and white blood cells of PNH patients with bone marrow failure syndromes.

      Trial Locations

      No locations found.